Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9450020 | 0.94 | NOS2 (0.31) | NOS2 | |
| SCHEMBL863535 | 0.91 | — | — | |
| SCHEMBL28441198 | 0.80 | — | — | |
| SCHEMBL3298616 | 0.79 | — | — | |
| SCHEMBL14178843 | 0.77 | — | — | |
| SCHEMBL8014507 | 0.77 | — | — | |
| SCHEMBL19462726 | 0.77 | — | — | |
| SCHEMBL12060984 | 0.77 | — | — | |
| SCHEMBL7002635 | 0.77 | — | — | |
| SCHEMBL230949 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 599 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108368098-B | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| US-11186596-B2 | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses | ADT PHARMACEUTICALS, LLC (US) | 2021-11-30 | — | — | US | claimed |
| WO-2021105101-A1 | [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-06-03 | — | — | WO | claimed |
| US-10975054-B2 | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | ADT PHARMACEUTICALS, LLC (US) | 2021-04-13 | — | — | US | claimed |
| EP-3784228-A1 | ANTICANCER INDENES, INDANES, AZAINDENES, AZAINDANES, PHARMACEUTICAL COMPOSITIONS AND USES | ADT Pharmaceuticals, LLC (US) | 2021-03-03 | — | — | EP | claimed |
| CN-112020354-A | Anti-cancer indenes, indanes, aza-indenes, aza-indanes, pharmaceutical compositions and uses | ADT制药有限责任公司 | 2020-12-01 | — | — | CN | claimed |
| US-20200048217-A1 | INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF | ADT PHARMACEUTICALS, LLC (US) | 2020-02-13 | — | — | US | claimed |
| EP-3390398-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | Syngenta Participations AG (CH) | 2018-10-24 | — | — | EP | claimed |
| WO-2017103223-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-06-22 | — | — | WO | claimed |
| EP-2598484-B1 | PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS (SI) | 2016-06-29 | — | — | EP | claimed |
| EP-0355544-A2 | Substituted decalin amines, method for their preparation and their use in pesticides | BAYER AG (DE) | 1990-02-28 | — | — | EP | claimed |
| EP-0355597-A1 | Substituted dioxolanylethylamines, process for their preparation, their use in pesticides, and intermediates | BAYER AG (DE) | 1990-02-28 | — | — | EP | claimed |
| EP-0356158-A1 | Aminopyrimidine derivative, process for preparing the derivative, and insecticide or bactericide containing the derivative | UBE INDUSTRIES, LTD. (JP) | 1990-02-28 | — | — | EP | claimed |
| US-4851405-A | FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | claimed |
| US-4800202-A | FUNGICIDES, PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1989-01-24 | — | — | US | claimed |
| EP-0289913-A2 | Parasiticidal agent based on substituted aminomethyl heterocycles | BAYER AG (DE) | 1988-11-09 | — | — | EP | claimed |
| EP-0281842-A1 | Aminomethyl-heterocycles | BAYER AG (DE) | 1988-09-14 | — | — | EP | claimed |
| EP-0278352-A2 | Aminomethyl-tetrahydro-furanes | BAYER AG (DE) | 1988-08-17 | — | — | EP | claimed |
| EP-0157876-A1 | HERBICIDAL 1-ARYL-$g(D)?2 -1,2,4-TRIAZOLIN-5-ONES | FMC Corporation (US) | 1985-10-16 | — | — | EP | claimed |
| WO-1985001637-A1 | HERBICIDAL 1-ARYL-DELTA2-1,2,4-TRIAZOLIN-5-ONES | FMC CORPORATION (US) | 1985-04-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048217-A1 | INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF | INSRR, INSR, BRCA1 | NOS2 889/4885 |
| US-11186596-B2 | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses | CCNA2, CDKN1A, CCNA1 | NOS2 210/4885 |
| US-10975054-B2 | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | INSRR, INSR, BRCA1 | NOS2 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.